Ekso Bionics Holdings, Inc.
EKSO
$0.442
$0.0122.79%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 23.27% | -16.59% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 23.27% | -16.59% | |||
| Cost of Revenue | 23.75% | -16.99% | |||
| Gross Profit | 22.86% | -16.23% | |||
| SG&A Expenses | 15.13% | 5.58% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.16% | -7.10% | |||
| Operating Income | 15.50% | -13.02% | |||
| Income Before Tax | -64.72% | 14.24% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -64.72% | 14.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -64.72% | 14.24% | |||
| EBIT | 15.50% | -13.02% | |||
| EBITDA | 17.92% | -15.17% | |||
| EPS Basic | -35.78% | 23.08% | |||
| Normalized Basic EPS | -35.74% | 23.04% | |||
| EPS Diluted | -35.78% | 23.08% | |||
| Normalized Diluted EPS | -35.74% | 23.04% | |||
| Average Basic Shares Outstanding | 21.32% | 11.45% | |||
| Average Diluted Shares Outstanding | 21.32% | 11.45% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||